Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

Lund University Hospital

Status: Withdrawn

Conditions: Respiratory Distress Syndrome; Persistent Pulmonary Hypertension

Treatments: Drug: iloprost

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00216931

2004-001551-11

Details and patient eligibility

About

The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.

Enrollment: 40 estimated patients

Sex: All

Ages: 24 to 48 hours old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Elevated arterial pulmonary pressure
• GA > 24 GW
• 24-48 hours of age
• Ventilator treatment

Exclusion criteria

• Congenital anomalies
• Severe hypotension

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)